Pulmonx Corp. (LUNG) News

Pulmonx Corp. (LUNG): $18.71

2.38 (+14.57%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter LUNG News Items

LUNG News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest LUNG News From Around the Web

Below are the latest news stories about Pulmonx Corp that investors may wish to consider to help them evaluate LUNG as an investment opportunity.

Pulmonx Corporation 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 25, 2022

Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results

REDWOOD CITY, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year of 2021 ended December 31, 2021.

GlobeNewswire | February 23, 2022

Pulmonx Corporation (LUNG) CEO Glen French on Q4 2021 Results - Earnings Call Transcript

No summary available.

Seeking Alpha | February 23, 2022

Pulmonx GAAP EPS of -$0.35 beats by $0.01, revenue of $13.7M misses by $0.54M

Pulmonx press release (NASDAQ:LUNG): Q4 GAAP EPS of -$0.35 beats by $0.01.Revenue of $13.7M (+39.8% Y/Y) misses by $0.54M.

Seeking Alpha | February 23, 2022

Pulmonx Corporation (LUNG) Q4 2021 Earnings Call Transcript

LUNG earnings call for the period ending December 31, 2021.

The Motley Fool | February 23, 2022

Pulmonx Corporation (LUNG) Reports Q4 Loss, Lags Revenue Estimates

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 0% and 3.53%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

Pulmonx to Present at the Citi 2022 Virtual Healthcare Conference

REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Citi 2022 Virtual Healthcare Conference on Thursday, February 24, 2022, at 8:45AM PT / 11:45AM ET. A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/. A

Yahoo | February 10, 2022

Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2021 after the close of trading on Wednesday, February 23, 2022. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET. Investors interested in listening to the conference

Yahoo | February 9, 2022

Siguler Guff Advisers, Llc Buys Fathom Digital Manufacturing Corp, Frontier Communications ...

New York, NY, based Investment company Siguler Guff Advisers, Llc (Current Portfolio) buys Fathom Digital Manufacturing Corp, Frontier Communications Parent Inc, Service Properties Trust, sells International Seaways Inc, Oscar Health Inc, Palantir Technologies Inc, Clover Health Investments Corp, Ambac Financial Group Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Siguler Guff Advisers, Llc.

Yahoo | January 27, 2022

Investors one-year losses grow to 53% as the stock sheds US$91m this past week

Even the best stock pickers will make plenty of bad investments. And there's no doubt that Pulmonx Corporation...

Yahoo | January 17, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6056 seconds.